Literature DB >> 1335245

Two types of inositol trisphosphate binding in cardiac microsomes.

Y Kijima1, S Fleischer.   

Abstract

Two distinct types of [3H]IP3 binding were found in canine cardiac microsomes with high (Kd = 21 nM, Bmax = 0.66 pmol/mg) and low affinity (Kd = 230 nM, Bmax = 2.9 pmol/mg). Also found were low affinity [3H]IP4 binding (Kd = 190 nM, Bmax = 4.5 pmol/mg) and high affinity [3H]IP6 binding (Kd = 10 nM, Bmax = 4.9 pmol/mg). The rank order of potency to displace these radioligands indicates that binding of IP3 and IP6 is ligand-specific. Sucrose gradient centrifugation of the detergent-solubilized cardiac microsomes indicates that the molecular size of the cardiac high affinity IP3 receptor is similar to that of the aortic smooth muscle IP3 receptor and smaller than that of the ryanodine receptor which migrates more rapidly. The IP4 and IP6 binding migrates more slowly than the IP3 receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335245     DOI: 10.1016/0006-291x(92)92262-v

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Location of ryanodine and dihydropyridine receptors in frog myocardium.

Authors:  Pierre Tijskens; Gerhard Meissner; Clara Franzini-Armstrong
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

2.  Characterization of inositolpolyphosphate binding to myocardial membranes.

Authors:  B Huisamen; E Ellis; M van Dyk; A Lochner
Journal:  Mol Cell Biochem       Date:  1996-09-06       Impact factor: 3.396

3.  Effects of ischaemia, reperfusion and alpha 1-adrenergic receptor stimulation on the inositoltrisphosphate receptor population in rat heart atria and ventricles.

Authors:  B Huisamen; R Mouton; L H Opie; A Lochner
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

4.  Inositol hexakisphosphate binding sites in rat heart and brain.

Authors:  K G Rowley; A L Gundlach; M Cincotta; W J Louis
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.

Authors:  E Kitchen; A M Condliffe; A G Rossi; C Haslett; E R Chilvers
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 6.  Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

Authors:  Jens Kockskämper; Aleksey V Zima; H Llewelyn Roderick; Burkert Pieske; Lothar A Blatter; Martin D Bootman
Journal:  J Mol Cell Cardiol       Date:  2008-06-15       Impact factor: 5.000

Review 7.  Inositol phosphates in the heart: controversy and consensus.

Authors:  E A Woodcock
Journal:  J Mol Med (Berl)       Date:  1995-06       Impact factor: 4.599

Review 8.  Inositolpolyphosphates and their binding proteins--a short review.

Authors:  B Huisamen; A Lochner
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

9.  Losartan attenuates phospholipase C isozyme gene expression in hypertrophied hearts due to volume overload.

Authors:  Melissa R Dent; Nina Aroutiounova; N S Dhalla; P S Tappia
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.